Paul Heidenreich, MD
Publication Details
-
Health and economic benefits of increased beta-blocker use following myocardial infarction.
JAMA. 2000; (21): 2748-54
beta-blockers are underused in patients who have myocardial infarction (MI), despite the proven efficacy of these agents. New evidence indicates that beta-blockers can have benefit in patients with conditions that have been considered relative contraindications. Understanding the consequences of underuse of beta-blockers is important because of the implications for current policy debates over quality-of-care measures and Medicare prescription drug coverage.
Help